Amicus Therapeutics Inc. buy Guggenheim
Start price
07.11.24
/
50%
€10.20
Target price
07.11.25
€13.91
Performance (%)
-25.49%
End price
08.11.25
€7.60
Summary
This prediction ended on 08.11.25 with a price of €7.60. The prediction for Amicus Therapeutics Inc. disappointed with a performance of -25.49%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 3.279% | 3.279% | 55.556% |
| iShares Core DAX® | -1,10 % | -6,08 % | 0,87 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 18,26 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 26,34 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 13,29 % |
Comments by Guggenheim for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at Guggenheim from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten